Discontinuation report EVUSHELD

Last updated on 2024-04-04 History
Report ID 224094
Drug Identification Number 02526271
Brand name EVUSHELD
Common or Proper name CILGAVIMAB TIXAGEVIMAB SOLUTION
Company Name ASTRAZENECA CANADA INC
Market Status DORMANT
Active Ingredient(s)
Strength(s) 150MG 150MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 2 single dose vials
ATC code J06BD
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2024-03-27
Remaining supply date 2023-01-09
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-04-02 English Compare
v2 2024-04-02 French Compare
v3 2024-04-02 English Compare
v4 2024-04-02 French Compare
v5 2024-04-04 English Compare
v6 2024-04-04 French Compare

Showing 1 to 6 of 6